title: Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
authors.forename: T J
authors.initials: TJ
authors.lastname: Hamblin
authors.forename: J A
authors.initials: JA
authors.lastname: Orchard
authors.forename: H
authors.initials: H
authors.lastname: Myint
authors.forename: D G
authors.initials: DG
authors.lastname: Oscier
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine